Multiple myeloma

• 100% — Symptomatic multiple myeloma
• 0% — Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS)

To support a 100% rating for symptomatic multiple myeloma, medical records showing a confirmed diagnosis of symptomatic multiple myeloma are central. Validated biomarkers accepted by the American Society of Hematology and the International Myeloma Working Group can establish this diagnosis, so laboratory results, bone marrow biopsy reports, imaging studies, and blood or urine protein tests that reflect those biomarkers are all relevant.

After the five-year period at 100%, a mandatory VA examination will assess your current status. At that point, records of ongoing treatment, specialist notes, and any test results showing whether your condition remains symptomatic or has changed would be relevant to what rating follows. Statements from you or your treating providers about how your symptoms affect your daily life and ability to work can also help give VA a full picture of your condition at any stage.

• Radiation — 38 CFR § 3.309(d)
• Camp Lejeune — 38 CFR § 3.309(f)
• Chronic disease — 38 CFR § 3.309(a)
• PACT Act — 38 U.S.C. § 1120; 38 CFR § 3.320b
• Agent Orange — 38 U.S.C. § 1116; 38 CFR § 3.309(e)